Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

GoodRx vs Piper

Piper costs $14 less a month, and both sell tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GoodRx logo

GoodRx

6.9
★★★★☆3.5/5

Best for: oral orforglipron alongside the injectables

Visit GoodRx →
VS
Piper logo

Piper

7.4
★★★★☆3.7/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Piper →

If you are choosing between GoodRx and Piper, the first difference is cost: Piper is $14 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. Piper leads our six-part score, 7.4 to 6.9.

GoodRx vs Piper price

Piper is the cheaper way in: $135 a month against $149 a month at GoodRx. That is $14 less each month (9% lower), or about $168 over a year of treatment.

Drug by drug: Tirzepatide is cheaper at Piper ($199 a month vs $299 a month).

Medications and formats

Both sell tirzepatide; only GoodRx lists orforglipron; only Piper lists semaglutide.

On format, GoodRx prices brand-name pens, while Piper prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.

Where each one treats patients

GoodRx lists 50 states, and Piper lists 50 states.

They overlap in 50 states.

Pricing

GoodRx

Foundayo (lowest dose, self-pay)Brand-name
$149/mo
orforglipron
Zepbound KwikPen (self-pay)Brand-name
$299/mo
tirzepatide

Piper

StartingCompounded
$135/mo
semaglutide
StartingCompounded
$199/mo
tirzepatide

What each price covers

Piper's price also covers the clinician visit, the medication itself and shipping, which GoodRx does not claim.

GoodRx does not say what its price includes.

Piper is silent on lab work and coaching.

That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.

GoodRx

Inclusions not disclosed.

Piper

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Piper scores 7.4 and GoodRx 6.9 out of 10.

GoodRx is stronger on value (5.0 vs 3.0).

Piper is stronger on user experience (8.0 vs 5.0), trust & safety (8.5 vs 6.0) and support (7.0 vs 5.0).

Effectiveness and accessibility are within half a point.

How we score

GoodRx

6.9/10

Overall

Piper

7.4/10

Value25%

5.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

5.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
8.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

5.0A
vs
B
7.0

FDA warning letters

Neither GoodRx nor Piper has an FDA warning letter on record with us.

Features & Coverage

FeatureGoodRxPiper
Starting Price$149/mo✓$135/mo
Features✓6 features3 features
States Available5050
Compounded—✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About GoodRx

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.

Read our full GoodRx review →

About Piper

Piper is a telehealth weight loss seller offering compounded GLP-1 medications at competitive prices.

Read our full Piper review →

Pros & Cons

GoodRx

What we like

  • Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
  • Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Serves all 50 states
  • We found no FDA warning letters issued to GoodRx

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Piper

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Piper

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Piper

Piper wins this one, 7.4 to 6.9, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $14 less each month than GoodRx. GoodRx fits better if oral orforglipron alongside the injectables is your priority.

Choose GoodRx if…

You want oral orforglipron alongside the injectables and an opening price near $149 a month.

Choose Piper if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $135 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

GoodRx vs Piper: FAQ

Piper. It starts at $135 a month; GoodRx starts at $149 a month, $14 more per month.
Yes, both sell tirzepatide. GoodRx adds orforglipron. Piper adds semaglutide.
Both list 50 states and share 50.
Only Piper includes the clinician visit, the medication itself and shipping.
GoodRx has none. Piper has none.
No. Neither GoodRx nor Piper pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.